Question

Difficulty: HardEndocrinology and Metabolism

A 38-year-old woman is evaluated in the outpatient clinic for progressive weight gain, proximal muscle weakness, and new-onset facial hair growth over the past 8 months. She takes no prescription or over-the-counter medications. Her temperature is 37.0°C (98.6°F), blood pressure is 158/98 mm Hg, pulse is 82/min, and BMI is 34 kg/m². Physical examination reveals facial plethora, a prominent dorsocervical fat pad, and wide, violaceous striae on the lower abdomen. Basic metabolic panel shows a serum potassium of 3.2 mEq/L and a fasting blood glucose of 145 mg/dL. The physician strongly suspects endogenous Cushing syndrome. Arrange the following diagnostic steps in the correct chronological sequence required to accurately diagnose and localize the etiology of this patient's condition.

  1. 1Perform an initial biochemical screening (e.g., late-night salivary cortisol or 24-hour urine free cortisol) to confirm hypercortisolism.
  2. 2If hypercortisolism is confirmed, measure plasma adrenocorticotropic hormone (ACTH) to determine if the condition is ACTH-dependent.
  3. 3If plasma ACTH is inappropriately normal or elevated, perform a high-dose dexamethasone suppression test.
  4. 4If the high-dose dexamethasone test successfully suppresses cortisol production, obtain a magnetic resonance imaging (MRI) scan of the pituitary gland.

Answer

The correct diagnostic algorithm sequence is to first confirm hypercortisolism with a screening test, followed by measuring plasma ACTH to determine ACTH dependence, then performing a high-dose dexamethasone suppression test to localize the source, and finally obtaining targeted anatomical imaging such as a pituitary MRI.
The diagnostic algorithm for Cushing syndrome is strictly phased to prevent diagnostic error. It must begin with establishing the diagnosis of hypercortisolism via screening tests. Once confirmed, the next phase is determining ACTH dependence by measuring plasma ACTH. For ACTH-dependent disease, dynamic testing (such as high-dose dexamethasone suppression) is performed to separate pituitary from ectopic sources. Finally, anatomical imaging is directed strictly by the biochemical findings.

Step-by-Step Solution

1
Recognize the clinical signs of hypercortisolism (central obesity, plethora, striae, hypokalemia) and exclude exogenous glucocorticoid use.
Determine the need for a definitive diagnostic workup for endogenous Cushing syndrome.
Classic physical and laboratory findings warrant an algorithmic approach to prevent misdiagnosis.
2
Select a primary screening test (e.g., 24-hour urine free cortisol, late-night salivary cortisol, or overnight low-dose dexamethasone suppression test).
Confirm pathologically elevated systemic cortisol levels.
Endogenous hypercortisolism must be biochemically proven before attempting to uncover its etiology.
3
Measure plasma ACTH concentration.
Identify the primary category of Cushing syndrome.
ACTH levels dictate the algorithm's next branch: suppressed ACTH points directly to an adrenal tumor, while normal or high ACTH points to a central or ectopic source.
4
Perform a high-dose dexamethasone suppression test for ACTH-dependent cases.
Differentiate pituitary Cushing disease from ectopic ACTH syndrome.
Pituitary adenomas retain some negative feedback sensitivity and will suppress at high steroid doses, whereas ectopic tumors (e.g., small cell lung cancer) typically will not.
5
Perform targeted anatomical imaging based strictly on the biochemical localization.
Image the pituitary gland (or alternative location based on prior steps).
Biochemical proof must precede anatomical imaging to avoid misleading findings from highly prevalent benign incidentalomas.

Key Concept

The diagnostic algorithm for Cushing syndrome rigorously requires biochemical confirmation of hypercortisolism, followed by determination of ACTH dependence, and functional localization before any anatomical imaging is performed.
Estimated Time:2m 0s
Rate this question